Zelnorm (tegaserod) is back, but only for certain patients

September 2007

Zelnorm (tegaserod) is back, but only for certain patients.

It's for women under 55 with chronic idiopathic constipation or irritable bowel syndrome with constipation who haven't responded to other treatments...or who were helped with Zelnorm in the past.

And these patients can't be at risk for cardiovascular disease.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

More patients will be getting vaccines for meningitis, hepatitis A, varicella, pertussis, and influenza
Osteoporosis Reclast, the first once-a-YEAR bisphosphonate for treating postmenopausal osteoporosis
Dermatology Some Daytrana (methylphenidate) patches are falling off
Infectious Diseases new HIV drug, Selzentry (maraviroc)
Gastroenterology Prilosec and Nexium might cause heart problems
Gastroenterology Zelnorm (tegaserod) is back, but only for certain patients
Geriatrics misuse of the Beers criteria to determine drug therapy in the elderly
Psychiatry Exelon (rivastigmine) now comes in a once-daily PATCH
Ophthalmology eyedrop called AzaSite for bacterial conjunctivitis or "pink eye"
Respiratory & Allergy new Rx antihistamine called Xyzal (ZEYE-zol)
Respiratory & Allergy Zyflo CR, a new extended-release version of zileuton for chronic asthma
Diabetes whether patients with type 2 diabetes benefit from monitoring their blood glucose
Diabetes how to treat diabetes during pregnancy
new requirement to use tamper-resistant pads for most written Medicaid prescriptions

Zelnorm (tegaserod) is back, but only for certain patients

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents